Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

According to the approval letter, the license restricts the use of the vaccine called Nuvaxovid to individuals aged 65 and ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to grant Novavax full approval – without restrictions -- by its April 1 target ...